Results 161 to 170 of about 260,172 (318)

Membrane Fusion‐Inspired Nanomaterials: Emerging Strategies for Infectious Disease and Cancer Diagnostics

Advanced Healthcare Materials, EarlyView.
Membrane fusion‐inspired nanomaterials offer transformative potential in diagnostics by mimicking natural fusion processes to achieve highly sensitive and specific detection of disease biomarkers. This review highlights recent advancements in nanomaterial functionalization strategies, signal amplification systems, and stimuli‐responsive fusion designs,
Sojeong Lee, Khulan Nyamzaya, Jueun Han, Yejin Song, Jihee Lee, Jung Hyun Jo, Seungmin Bang, Eun‐Kyung Lim, Seungjoo Haam, Eunjung Kim   +9 more
wiley   +1 more source

Socioeconomic status is associated with symptom severity and sickness absence in people with infectious intestinal disease in the UK [PDF]

, 2017
Tanith C. Rose, Natalie Adams, Ben Barr, Jeremy Hawker, S. O’Brien, Mara Violato, Margaret Whitehead, David Taylor‐Robinson   +7 more
openalex   +1 more source

Nanocarrier‐Based Targeting of Pattern Recognition Receptors as an Innovative Strategy for Enhancing Sepsis Therapy

Advanced Healthcare Materials, EarlyView.
This review highlights recent progress in nanocarriers targeting pattern recognition receptors (PRRs), including Toll‐like and NOD‐like receptors, for enhancing the treatment of bacterial sepsis and related complications. These nanomedicines deliver antibiotics and anti‐inflammatory agents while modulating immune responses.
Eman A. Ismail, Vincent O. Nyandoro, Calvin A. Omolo, Thirumala Govender   +3 more
wiley   +1 more source

Prevalence and factors associated with infectious intestinal diseases in Ras Al Khaimah, United Arab Emirates, 2017: A population-based cross-sectional study [PDF]

, 2019
F. Al Alkeem, Tom Loney, Faisal Aziz, Iain Blair, Ágnes Sonnevend, Mohamud Sheek‐Hussein   +5 more
openalex   +1 more source

Detection of Intestinal Fungi in Chickens Naturally Infected with Infectious Bursal Disease

, 2021
Ayman M. Khalifah, Dalia M. Sedeek, Hanaa S. Fedawy, Mohamed Bosila, Hoda M. Mekky, Kh. M. Elbayoumi, Mohamed Amer   +6 more
openalex   +1 more source

Harnessing 3D models to uncover the mechanisms driving infectious and inflammatory disease in the intestine

BMC Biology
AbstractRepresentative models of intestinal diseases are transforming our knowledge of the molecular mechanisms of disease, facilitating effective drug screening and avenues for personalised medicine. Despite the emergence of 3D in vitro intestinal organoid culture systems that replicate the genetic and functional characteristics of the epithelial ...
Diana Micati, Sara Hlavca, Wing Hei Chan, Helen E. Abud   +3 more
openaire   +3 more sources

Interstitial N‐Strengthened Copper‐Based Bioactive Conductive Dressings Combined with Electromagnetic Fields for Enhanced Wound Healing

Advanced Healthcare Materials, EarlyView.
This study developed a nitrogen‐strengthened copper‐iron‐zinc (N‐CuFeZn) alloy bioactive dressing integrated with electromagnetic stimulation. The coaxial dressing, made from 0.04 mm filaments with 1120 MPa tensile strength, showed that electromagnetic activation enhanced therapeutic outcomes by increasing VEGF expression, promoting angiogenesis (2.1 ...
Xiaohui Qiu, Xianrui Wu, Shaohua Wang, Jie Gu, Senhao Ying, Jiaohao Mo, Chen Jing, Huiliang Cao, Zhongchang Wang, Jianda Zhou   +9 more
wiley   +1 more source

Lividomycin Therapy in Intestinal Infectious Diseases with Special Reference to the Combination Use with AB-PC

, 1973
Ryōji Takahashi, Sadaharu Kato
openalex   +2 more sources

Association between Sanitary toilet coverage rate and intestinal infectious disease in Jiangsu Province, China [PDF]

, 2019
Tingting Chen
openalex   +1 more source

Safety Evaluation of Repeated Application of Polymeric Microarray Patches in Miniature Pigs

Advanced Healthcare Materials, EarlyView.
This study demonstrates the safety of repeated application of three types of microarray patches (MAPs), hydrogelforming, dissolving, and implantable, over four weeks in miniature pigs. No adverse skin or systemic effects were observed, supporting the clinical potential of MAPs as safe and effective drug delivery platforms.
Qonita Kurnia Anjani, Aaron R. J. Hutton, Peter E. McKenna, Eneko Larrañeta, Ryan F. Donnelly   +4 more
wiley   +1 more source